LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

Search

Intuitive Surgical Inc

Fechado

SetorSaúde

500.19 0.64

Visão Geral

Variação de preço das ações

24h

Atual

Mín

491.06

Máximo

505.23

Indicadores-chave

By Trading Economics

Rendimento

90M

800M

Vendas

361M

2.9B

P/E

Médio do Setor

62.896

66.845

Margem de lucro

27.894

Funcionários

17,021

EBITDA

70M

1.1B

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+30.18% upside

Dividendos

By Dow Jones

Próximos Ganhos

21 de abr. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-16B

176B

Abertura anterior

499.55

Fecho anterior

500.19

Sentimento de Notícias

By Acuity

22%

78%

51 / 351 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bearish Evidence

Intuitive Surgical Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

21 de out. de 2025, 23:55 UTC

Ações em Alta

Stocks to Watch: DraftKings, Texas Instruments, Intuitive Surgical, Pegasystems

21 de out. de 2025, 21:14 UTC

Ganhos
Grandes Movimentos do Mercado

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth -- Update

21 de out. de 2025, 20:38 UTC

Ganhos

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth

22 de jul. de 2025, 21:13 UTC

Ganhos

Intuitive Surgical Logs Higher Profit, Revenue in 2Q

17 de fev. de 2026, 14:48 UTC

Ganhos

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

23 de jan. de 2026, 16:07 UTC

Ganhos

Intuitive Surgical Stock Beats Earnings Estimates. The Stock Is Barely Moving. -- Barrons.com

23 de jan. de 2026, 12:58 UTC

Ganhos

Intuitive Surgical Stock Rises on Earnings. What Wall Street Is Saying. -- Barrons.com

22 de jan. de 2026, 21:11 UTC

Ganhos

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

22 de jan. de 2026, 21:11 UTC

Ganhos

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

22 de jan. de 2026, 21:10 UTC

Ganhos

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

22 de jan. de 2026, 21:05 UTC

Ganhos

Intuitive Surgical 4Q EPS $2.21 >ISRG

22 de jan. de 2026, 21:05 UTC

Ganhos

Intuitive Surgical 4Q Rev $2.87B >ISRG

22 de jan. de 2026, 21:05 UTC

Ganhos

Intuitive Surgical 4Q Net $794.8M >ISRG

22 de jan. de 2026, 21:05 UTC

Ganhos

Intuitive Surgical 4Q Adj EPS $2.53 >ISRG

22 de jan. de 2026, 21:05 UTC

Ganhos

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 532.00 >ISRG

30 de out. de 2025, 12:38 UTC

Ganhos

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

30 de out. de 2025, 12:01 UTC

Ganhos

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

22 de out. de 2025, 15:42 UTC

Ganhos

Intuitive Surgical Stock Jumps on Earnings. Its Newest Surgical Robot Is Going Gangbusters. -- Barrons.com

22 de out. de 2025, 12:34 UTC

Ganhos

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

22 de out. de 2025, 11:49 UTC

Ganhos

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

21 de out. de 2025, 20:08 UTC

Ganhos

Intuitive Surgical: Worldwide Da Vinci Procedure Growth of Approximately 17% to 17.5% in 2025, Compared to 17% in 2024 >ISRG

21 de out. de 2025, 20:08 UTC

Ganhos

Intuitive Surgical: Non-GAAP Gross Profit Margin to Be Within a Range of 67% and 67.5% of Rev in 2025, Compared to 69.1% in 2024 >ISRG

21 de out. de 2025, 20:05 UTC

Ganhos

Intuitive Surgical 3Q Rev $2.51B >ISRG

21 de out. de 2025, 20:05 UTC

Ganhos

Intuitive Surgical 3Q Net $704.4M >ISRG

21 de out. de 2025, 20:05 UTC

Ganhos

Intuitive Surgical 3Q Adj EPS $2.40 >ISRG

21 de out. de 2025, 20:05 UTC

Ganhos

Intuitive Surgical 3Q Da Vinci Surgical Systems Shipped 427.00 >ISRG

21 de out. de 2025, 20:05 UTC

Ganhos

Intuitive Surgical 3Q EPS $1.95 >ISRG

22 de jul. de 2025, 20:14 UTC

Ganhos

Intuitive Surgical Sees FY25 Non-GAAP Gross Profit Margin to Be Within Range of 66% and 67% >ISRG

22 de jul. de 2025, 20:13 UTC

Ganhos

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15.5% to 17% >ISRG

22 de jul. de 2025, 20:13 UTC

Ganhos

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 10,488 Systems as of June 30 >ISRG

Comparação entre Pares

Variação de preço

Intuitive Surgical Inc Previsão

Preço-alvo

By TipRanks

30.18% parte superior

Previsão para 12 meses

Média 647.56 USD  30.18%

Máximo 750 USD

Mínimo 550 USD

Com base em 19 analistas de Wall Street que oferecem metas de preço de 12 meses para Intuitive Surgical Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

19 ratings

14

Comprar

5

Manter

0

Vender

Pontuação Técnica

By Trading Central

514.59 / 539.05Suporte e Resistência

Curto Prazo

Weak Bearish Evidence

Médio Prazo

Weak Bullish Evidence

Longo Prazo

Strong Bullish Evidence

Sentimento

By Acuity

51 / 351 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
help-icon Live chat